COMMUNIQUÉS West-GlobeNewswire

Annovis Provides Corporate Updates and Reports Third Quarter 2026 Financial Results
13/11/2026
Last patient, last visit of the 6-month treatment period in the Phase 3 DUET-AD study is scheduled for December 31, 2026, with database lock on February 8, 2027, and data readout in March 2027 Parkinson’s disease open- [...]
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
13/11/2026
CONSHOHOCKEN, Pa., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences: The fireside [...]
Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth
13/11/2026
WOBURN, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic [...]
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance
13/11/2026
- Ended third quarter with $24.1 million in cash and restricted cash - Expects positive fourth quarter earnings between $0.01 and $0.04 per share TARPON SPRINGS, Fla., November 13, 2026 – Allarity Therapeutics, Inc. (“ [...]
Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece
13/11/2026
Building on Nanox.AI's existing deployment in Athens, the agreement supports commercial expansion in Greece through Medworks ' established market presence. PETACH TIKVA, Israel, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Nanox [...]
InspireMD Announces Pricing of $37.5 Million Public Offering
13/11/2026
MIAMI, Nov. 13, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced the pricing of [...]
SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion
13/11/2026
Promotes Dr. Vishwa Srivastava to President and Appoints Gary Lo as Chief Financial Officer FORT LAUDERDALE, Fla., Nov. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS [...]
AIM ImmunoTech Approaches Major Clinical Inflection Point with Phase 2 Pancreatic Cancer Data Expected Q1 2027; Reports Third Quarter 2026 Financial Results
13/11/2026
Expanding scientific rationale for Ampligen ® in the evolving pancreatic cancer treatment landscape, including potential complementary approaches with RAS-targeted therapies Ampligen dosing completed in Phase 2 DURIPANC [...]
Kyntra Bio to Report Third Quarter 2026 Financial Results
13/11/2026
SAN FRANCISCO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio, Inc. (Nasdaq: KYNB) will announce third quarter 2026 financial results on Monday, November 16 after market close. Kyntra Bio will also conduct a conference [...]
Wave Life Sciences Highlights WVE-007 (INHBE siRNA) Progress at ObesityWeek® 2026
13/11/2026
INLIGHT Phase 1 data continue to support WVE-007’s novel mechanism of action to improve body composition by inducing fat loss without muscle loss, and support a once- or twice-yearly dosing regimen Six-month data from [...]
Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
13/11/2026
BURLINGTON, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present [...]
Sienna Announces November Dividend
13/11/2026
MARKHAM, Ontario, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Cannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use Disorders
13/11/2026
VANCOUVER, British Columbia, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana, multi-drug, and alcohol breath [...]
NeOnc Showcases Two Brain Cancer Drug Programs at SNO as FDA Meetings Approach
13/11/2026
DENVER, Nov. 13, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews ) — NeOnc Technologies Holdings (NASDAQ: NTHI) reaches an important clinical-development milestone today as it presents updated findings from two investigational [...]
Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% for Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months at the ACAAI Annual Scientific Meeting
13/11/2026
New INTEGUMENT-INFANT trial results demonstrate improvements in itch, reductions in symptoms, and improvements in quality of life for infants with atopic dermatitis and their families Findings further support [...]
ANGEL Brings Professional Coffee Water Solutions to the 2026 San Francisco Coffee Festival
13/11/2026
SAN FRANCISCO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- ANGEL served as the Official Water Partner of the 2026 San Francisco Coffee Festival, held on November 7–8 in San Francisco, California. Through this partnership, ANGEL [...]
Henrik Juuel to Step Down as Chief Financial Officer of Bavarian Nordic in 2027
13/11/2026
COPENHAGEN, Denmark, November 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today that Henrik Juuel has informed the Board of Directors of his decision to step down as Chief Financial Officer. Henrik Juuel will [...]
Bavarian Nordic Reports Strong Travel Health Growth in the Third Quarter and Confirms Solid Momentum for the Rest of the Year
13/11/2026
COPENHAGEN, Denmark, November 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the third quarter and first nine months of 2026. Financial highlights [...]
Bavarian Nordic Launches Next Tranche of DKK 750 Million Share Buy-Back Program
13/11/2026
COPENHAGEN, Denmark, November 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today launches the second tranche of the share buy-back program announced on August 21, under which the Company intends to repurchase own shares [...]

Pages